Treating challenging SFA disease in the era of paclitaxel uncertainty

Peter Soukas, M.D., Providence, Rhode Island


Complex aortoiliac occlusive disease: Achieving differentiated performance through advanced technology

Mohammad Ansari, M.D., Lubbock, Texas

*This program is developed and offered by W. L. Gore & Associates. This is not an official program of Cardiovascular Innovations Foundation.


PFO closure: The future is now

Joseph Aragon, M.D., FACC, FSCAI, Santa Barbara, California

Jonathan M. Tobis, M.D., Los Angeles, California

*This program is developed and offered by W. L. Gore & Associates. This is not an official program of Cardiovascular Innovations Foundation.